In ovarian cancer SOX2 ectopic overexpression promotes tumor cell resistance to several chemotherapeutic compounds, such as cisplatin, carboplatin, and paclitaxel, by altering the homeostasis between pro- and anti-apoptotic proteins. The gene discussed is SOX2; the disease is ovarian carcinoma.